Cinnarizin und dimenhydrinat

The AOK Nordost The health fund in Germany from Europe region has released this tender for Cinnarizin und dimenhydrinat The subject of this publication is the conclusion of agreements in accordance with Section 130a 8 SGB V to various active ingredients active ingredient combinations as part of a so-called open house procedure Under the specification of uniform contractual conditions and uniform access procedures all suitable and interested pharmaceutical companies or communities of pharmaceutical companies is offered the conclusion or accession to a discount contract in accordance with Section 130a 8 SGB V for the active ingredient active ingredient combination Interested pharmaceutical companies can download the order documents participation documents and contract at https www dtvp de satellite notice cxp4y6m5l3z after registration The e-mail address named in the client for the purpose of the unrestricted and complete fee-free access of the order documents has no existence Information can be obtained exclusively via your registration on the DTVP awarding platform under the communication rider Information and answers about other places are not binding The prerequisite for the conclusion of a contract is that the interested pharmaceutical company fully completed and signed the required procedural documents Every pharmaceutical company that meets the participation requirements and documents this by signing the declarations and the discount contract can join the discount contract There is no exclusivity The accession or conclusion of the contract can take place at any time and on the same conditions Individual contract negotiations are not carried out The start of the contract can only be one month The earliest start of the contract is 01 06 2025 Based on this the contract term is a maximum of 23 months The contract ends at the latest on April 30 2027 regardless of the date of the contract The offer must be available at the start of the contract on June 1st 2025 by April 25 2025 at the latest However no contracts on the part of the AOK Nordost are concluded before 05 05 2025 For a later start of the contract the offer of the offers of the 5th of the previous month is the submission period Example Start of the contract 01 07 2025 deadline for submitting the offer 05 06 2025 If the AOK Nordost gives an exclusive surcharge for the active ingredient combination of active ingredients during the contract term the contractual regulations concluded as part of this publication apply The present publication is not the allocation of a public mandate within the meaning of the award coordination directive 2014 24 EU of the European Parliament and the Council or the Public Property In order to ensure a largest degree of transparency for the intended contract conclusions the publication is published in the supplement to the Official Journal of the European Union In the absence of a corresponding publication form this form of the order announcement is used The resulting conceptual requirements such as the procedural name open procedure are only due to the use of this announcement form and the publication platform Another meaning in particular a submission under public procurement law unless they are obliged for legal reasons is not associated with this The assigned orders are announced exclusively at the following link https www aok de gp arzneimittel RABATTRAEGE- HINTERGRAND with tender notice no. 250402_OH FAM NOST_85_GW published on 05 Apr 2025. The tender is due to expire on 06 Mar 2027. This tender is sourced from Vergabe and is eligible for suppliers interested in Pharmaceutical products. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 7537423.